Stocks and Investing Stocks and Investing
Tue, September 1, 2020
Mon, August 31, 2020

David Lebovitz Maintained (ASND) at Buy with Increased Target to $179 on, Aug 31st, 2020


Published on 2024-10-27 12:51:26 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $177 to $179 on, Aug 31st, 2020.

David has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $158 on, Friday, August 28th, 2020
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $173 on, Wednesday, May 20th, 2020
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $208 on, Wednesday, May 20th, 2020
Contributing Sources